Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Ansell Limited
  6. News
  7. Summary
    ANN   AU000000ANN9

ANSELL LIMITED

(ANN)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 11/26
31.85 AUD   -0.22%
11/11Mining boost helps Australia shares snap four-day losing streak
RE
11/11Ansell Limited Updated Constitution
PU
11/10Ansell Limited Appoints Morten Falkenberg as Director
CI
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ansell : Awarded Room Turnover Products Agreement with Premier

09/01/2021 EST

8 Sept 2021 - ISELIN, NJ, Ansell hasbeen awarded a group purchasing agreement for Room Turnover Products with Premier. Effective September 1, 2021, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for a wide variety of room turnover products and turnover packs.

'Ansell is excited for the opportunity to support Premier members in their safety initiatives by providing innovative solutions to help improve room turnover efficiency, reduce the risk of cross-contamination, and help improve patient outcomes' said Angie Hughes, Senior Director, US Medical Sales, Ansell.

Ansell provides a comprehensive portfolio of room turnover products including patented STAT-BLOC™ disposable linens with AMT™ Antimicrobial Technology which provide complete protection against bacterial migration and are at least 99% effective against MRSA, E. coli, CRE and COVID-19*. Other products available individually or as part of standard or custom turnover packs include patient positioning straps, draw sheets, mop heads, heavy-duty waste bags, fluid solidifier, drain bags, wagon covers and more.

Premier is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and 200,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

ENDS

Disclaimer

Ansell Limited published this content on 01 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 September 2021 16:11:01 UTC.


ę Publicnow 2021
All news about ANSELL LIMITED
11/11Mining boost helps Australia shares snap four-day losing streak
RE
11/11Ansell Limited Updated Constitution
PU
11/10Ansell Limited Appoints Morten Falkenberg as Director
CI
10/06Ansell Limited Announces Greenfield Investment in India
CI
09/01ANSELL : Awarded Room Turnover Products Agreement with Premier
PU
08/30ANSELL LIMITED : Ex-dividend day for final dividend
FA
08/23ANSELL : Net Profit Surges in FY21 on Higher Sales of Personal Safety Products; Shares Slu..
MT
08/23Ansell Limited Announces Executive Changes, Effective September 1, 2021
CI
08/23Ansell Limited Announces Appointment of Morten Falkenberg as an Independent Non-Executi..
CI
08/23Ansell Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, ..
CI
More news
Analyst Recommendations on ANSELL LIMITED
More recommendations
Financials (USD)
Sales 2022 1 992 M - -
Net income 2022 224 M - -
Net Debt 2022 133 M - -
P/E ratio 2022 13,0x
Yield 2022 3,35%
Capitalization 2 781 M 2 779 M -
EV / Sales 2022 1,46x
EV / Sales 2023 1,43x
Nbr of Employees 14 159
Free-Float 99,9%
Chart ANSELL LIMITED
Duration : Period :
Ansell Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANSELL LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 22,69 $
Average target price 29,55 $
Spread / Average Target 30,3%
EPS Revisions
Managers and Directors
Neil I. Salmon Chief Executive Officer & Managing Director
Zubair Javeed Chief Financial Officer
John Andrew Bevan Chairman
Giri Peddinti Global Chief Information Officer & Senior VP
John Marsden Senior Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
ANSELL LIMITED-8.42%2 779
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374